Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine

NCT02501421 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Research Institute for Biological Safety Problems

Collaborators